PSTV
Plus TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PSTV Profile
Plus Therapeutics, Inc.
A U.S. pharmaceutical company that develops innovative, targeted radiotherapeutics for cancers
4200 Marathon Blvd., Suite 200, Austin, TX 78756
--
Plus Therapeutics, Inc. The company was incorporated as a California general partnership in July 1996 and was incorporated in Delaware in May 1997. Initially, it was known as MacroPore Biosurgery, and before that it was MacroPore. The Company is a US pharmaceutical company developing central nervous system (" CNS ") cancer-targeted radiotherapy drugs with advanced platform technology. The Company's novel radiopharmaceutical formulations and therapeutic drug candidates are designed to deliver safe and effective radiation doses to tumors. To achieve this, the company has developed innovative methods of drug formulation, including encapsulating radionuclides such as rhenium isotopes with nanoliposomes and microspheres.
